Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Condition:   Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.Intervention:   Biological: Darbepoetin alfaSponsor:   AmgenRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2012 Category: Research Source Type: clinical trials

Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Condition:   Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.Intervention:   Biological: Darbepoetin alfaSponsor:   AmgenRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2012 Category: Research Source Type: clinical trials

Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Condition:   Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.Intervention:   Biological: Darbepoetin alfaSponsor:   AmgenRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2012 Category: Research Source Type: clinical trials

Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Condition:   Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.Intervention:   Biological: Darbepoetin alfaSponsor:   AmgenRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2012 Category: Research Source Type: clinical trials

Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease
Conditions:   Anemia;   Chronic Kidney DiseaseIntervention:   Drug: Darbepoetin alfaSponsor:   AmgenNot yet recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2011 Category: Research Source Type: clinical trials

Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease
Conditions:   Anemia;   Chronic Kidney DiseaseIntervention:   Drug: Darbepoetin alfaSponsor:   AmgenNot yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2011 Category: Research Source Type: clinical trials

Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease
Conditions:   Anemia;   Chronic Kidney DiseaseIntervention:   Drug: Darbepoetin alfaSponsor:   AmgenNot yet recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2011 Category: Research Source Type: clinical trials

Darbepoetin Alfa in Anemic Low or Intermediate-1 Risk MDS Subjects
Condition:   MDSInterventions:   Drug: Darbepoetin alfa;   Drug: PlaceboSponsor:   AmgenActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2011 Category: Research Source Type: clinical trials

Darbepoetin Alfa in Anemic Low or Intermediate-1 Risk MDS Subjects
Condition:   MDSInterventions:   Drug: Darbepoetin alfa;   Drug: PlaceboSponsor:   AmgenActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2011 Category: Research Source Type: clinical trials